Recent Articles from Investor Brand Network

Market Street was featured in an article that highlights its capital markets and financial advisory services for middle-market healthcare companies navigating reimbursement uncertainty, industry consolidation, heightened compliance scrutiny and increasingly selective investors. With potential Medicare laboratory reimbursement cuts beginning in 2027, lenders and private equity sponsors are placing greater emphasis on revenue diversification, payer relationships, regulatory compliance and sustainable cash flow when evaluating financing and acquisition opportunities. Market Street supports healthcare businesses through debt financing, private equity raises, mergers and acquisitions, valuation and strategic advisory services, connecting clients with banks, private credit funds, institutional investors and other potential capital sources. With more than $3 billion in completed transactions and a network of over 8,000 investors and financial institutions, the firm provides advisory capabilities intended to help middle-market operators navigate complex financing decisions and growth opportunities.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Wrap Technologies (NASDAQ: WRAP) is expanding its public safety technology strategy by connecting remote restraint, scenario-based training, evidence management and emerging threat-detection systems into a more integrated offering. Its portfolio includes the BolaWrap 150 restraint device, WRAP Reality virtual reality training simulator and WrapShield platform, which initially focuses on detecting and responding to unmanned aircraft threats. The company recently appointed veteran law enforcement instructor John “Chappy” Chapman as vice president of Training and Missions to oversee a planned four-level instructor credentialing framework, digital learning expansion and broader adoption of its Non-Lethal Response doctrine. WRAP is also developing Wraptor MX, a multi-shot restraint platform, and exploring additional counter-drone capabilities.

VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug development programs, aiming to improve the clinical relevance of research findings while reducing animal testing. The company is implementing New Approach Methodologies (“NAMs”), including three-dimensional tumor spheroid models and patient-derived tumor models, in support of its BiTAC(R) T-cell engagers, antibody-drug conjugates and bispecific antibody-drug conjugates. VERAXA reported that its lead BiTAC T-cell engager demonstrated selective, potent T-cell-mediated tumor-cell killing across 10 patient-derived non-small cell lung cancer models, while relevant controls showed minimal activity. The ex vivo study required approximately 10 mice, compared with an estimated 200 or more for comparable in vivo efficacy studies, according to the company. The findings support VERAXA’s dual-targeting approach, which is designed to direct immune activity toward cancer cells expressing two selected targets, and its broader strategy of using human-relevant models in preclinical research.

Anthropic has taken a major step toward becoming a publicly traded company, filing paperwork on Monday for an initial public offering that could rank among the biggest market debuts ever.

According to a recent analysis conducted by Ember, national energy storage targets for 2030 collectively fall 45% short of the 1,500-gigawatt global target agreed at COP29, despite rapid growth in actual installations.

REV (TSX.V: REVX) (OTCID: REVFF) announced the identification of highly elevated helium concentrations across multiple geological horizons during its maiden drilling program at the Aden Dome Property along the Alberta-Montana border. Geophysical logs also indicated exceptional reservoir properties, supporting the potential for a new helium discovery in the Sweet Grass Corridor. The company has contracted a service rig to begin evaluating the identified zones during the week of Nov. 2, 2026, with testing focused on pressure, reservoir quality, gas composition and potential deliverability. Drilling also encountered a strong natural hydrogen show in the basement complex near the Basal Cambrian Sandstone Formation.

Quantum BioPharma (NASDAQ: QNTM) has signed a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to support the Phase 2 clinical trial of Lucid-MS, its investigational drug candidate for progressive multiple sclerosis (“MS”). Following U.S. Food and Drug Administration clearance of its Investigational New Drug application in August 2026, the agreement moves the program toward clinical implementation with a contract research organization experienced in central nervous system and MS studies. Unlike many existing MS treatments that primarily target the immune system, Lucid-MS is designed to protect myelin, the protective coating around nerve fibers, by inhibiting PAD2, an enzyme implicated in myelin damage. The randomized, double-blind, placebo-controlled trial will evaluate the candidate’s safety, tolerability and efficacy using clinical and radiological measures. Although preclinical research and Phase 1 testing have provided encouraging findings, Lucid-MS remains investigational, and the company has not yet announced enrollment dates or trial sites.

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements.

Hydrofarm (NASDAQ: HYFM) announced the closing of its previously disclosed registered direct offering of 1,599,400 common shares at $0.905 per share and concurrent private placement of 7,611,575 unregistered common shares or pre-funded warrants and 9,210,975 common stock purchase warrants. The transactions generated approximately $8.3 million in gross proceeds before fees and expenses. Chairman and CEO Bill Toler, along with other company officers, directors and their affiliates, participated on the same terms as other investors. Hydrofarm intends to use the net proceeds for general corporate purposes. ThinkEquity served as sole placement agent and advisor.

Used electric vehicle sales set records in September as new EV purchases fell sharply, a split that reframes the dominant narrative about American consumer appetite for electric cars. The divergence points to price as the main variable rather than any fundamental resistance to the technology.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

A recently-proposed company-vehicle policy has the potential to create hundreds of thousands of new job opportunities across Europe at a time when the continent’s auto sector is facing a historic decline . According to the Fraunhofer ISI Study, company vehicles represent the fastest way for Europe to turn its ongoing transition to battery electric vehicles (BEVs) into an active job creator.

Recent reports show that the price of gold remains under pressure as rising crude oil prices fuel inflation concerns and strengthen expectations of tighter U.S. monetary policy, offsetting support from declining Treasury yields and geopolitical uncertainty.

Immunotherapy is a relatively new approach in the treatment of cancer and it has had profound effects on the patients who are responsive to these treatments. Researchers have been working to find ways of making the therapy effective for more categories of patients, since the current immunotherapies don’t work for everyone.

Energy Ministers from Canada and Turkey have signed a deal that enters both countries into a strategic bilateral partnership focused on renewable energy, nuclear energy, and liquefied natural gas (LNG). Canada’s Minister of Energy & Natural Resources Timothy Hodgson met with Turkey’s Minister of Energy & Natural Resources during an Istanbul summit and signed the cooperation statement in the presence of Turkish President Recep Tayyip Erdoğan and Canadian Prime Minister Mark Carney.

Israeli Prime Minister B. Netanyahu has proposed crypto as a possible way for the country to maintain financial channels if international sanctions increasingly restrict its access to the global banking system.

Europe’s car industry is at a very important point . For many years, gasoline and diesel cars have been a big part of life in Europe. They have supported factories, jobs, and travel. But now, electric cars, high fuel prices, climate goals, and strong competition from other countries are forcing Europe to make a big choice.

China has proposed a significant update to its electricity spot market rules that would allow solar and wind farms to trade power alongside their co-located battery systems, a change that could reshape how renewable energy is priced and dispatched across the country’s national grid.

SS Innovations (NASDAQ: SSII), a developer of innovative surgical robotic technologies, showcased its surgical robotics platform in a series of remote operations during October medical conferences in Spain and India, including a robotic-assisted cardiac procedure performed by a surgeon approximately 7,500 miles from the patient ( https://ibn.fm/EZFDT ).

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising.

This article has been disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising.

This article has been disseminated on behalf of Shelfie-Tech Ltd. and may include paid advertising.

Nightfood Holdings (OTCQB: NGTF) is featured in a NetworkNewsAudio Audio Press Release (“APR”) titled “Inspection, Automation Equipment Could Be Overlooked Winners of the AI Buildout.” The audio release examines growing demand for advanced semiconductor inspection and automation equipment as artificial intelligence (“AI”) and high-performance computing drive increasingly complex chip packaging requirements. The editorial highlights industry participants KLA and Onto Innovation, whose inspection technologies address defect detection and quality control in advanced semiconductor manufacturing.

Silynxcom (NYSE American: SYNX), a developer of advanced soldier-worn tactical communication solutions, is developing an artificial intelligence-powered wearable drone-detection system designed to warn soldiers of approaching unmanned aircraft, marking a strategic move by the tactical communications company into the counter-drone defense market.

FingerMotion (NASDAQ: FNGR) announced that it has entered into a non-binding term sheet with BlueFlare Group Holdings Inc., a Calgary-based developer of behind-the-meter power generation and modular high-performance computing infrastructure, regarding a potential business combination. The proposed transaction would create a North American infrastructure company focused on providing on-site power and computing capacity to enterprise customers. Under the proposed terms, BlueFlare shareholders and certain management and advisory parties would hold approximately 80% of the combined company on a fully diluted basis. Upon completion, FingerMotion would be renamed BlueFlare Inc. and trade on Nasdaq under the ticker symbol BFLR.

American Fusion (OTC: AMFN) is advancing testing of its Texatron(TM) Fusion Engine(TM) as it explores opportunities to supply electricity to AI data centers and other power-intensive customers. In a recent AGORACOM interview, Executive Chairman Brent Nelson discussed the company’s 500-kW and 5-MW pre-production systems, plans for larger 10-MW and 20-MW configurations, and a development roadmap covering 12 authorized model classes ranging from approximately 500 kW to 1 GW. The company is targeting documented test results demonstrating energy generation and capture, with a goal of reaching unity or beyond unity by the end of 2026. American Fusion is also exploring a potential commercial model involving on-site power generation and electricity sales through power purchase agreements, citing growing demand for reliable power from AI infrastructure. Management has indicated that successful testing could pave the way for a test-unit deployment and potentially commercial electricity production in 2027.

Versus Systems (NASDAQ: VS) is expanding its audience-engagement offerings through Drinkfinger, a QR-enabled beverage carrier that connects live-event attendees with mobile games, rewards and branded content. In a recent IBN Stock2Me Podcast appearance, CEO Luis Goldner and other members of the leadership team discussed plans to target Latin American markets, including Brazil and Mexico, where sporting events, concerts and festivals offer potential opportunities for interactive promotions. The initiative complements Versus’ existing Winfinite platform, which provides customizable web-based games for marketing campaigns, and Filter Fan Cam, which uses augmented-reality effects to enhance live-event experiences and create sponsorship opportunities. Management also discussed the growing relationship between artificial intelligence and cybersecurity, emphasizing the importance of protecting data and digital infrastructure as AI adoption expands. Through its product portfolio, Versus aims to connect physical venues with digital engagement experiences.

Disseminated on behalf of SuperQ Quantum Computing Inc. and may include paid advertisements.

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed the company’s efforts to advance its regenerative cartilage repair technology, GelrinC, as orthopedic medicine increasingly emphasizes durable, long-term treatment outcomes. The company’s lead product is a cell-free, off-the-shelf degradable hydrogel implant designed to support the regeneration of knee cartilage, gradually resorbing over approximately six to nine months as new tissue fills the treated area. Regentis reports that its Pilot/Phase II study showed 100% greater pain improvement compared with traditional microfracture treatment, while 24-month follow-up results showed a mean MOCART score of 88.8 out of 100, an MRI-based measure of cartilage repair quality. GelrinC has received a CE mark in Europe, providing a pathway for commercialization in that market, while Regentis advances its pivotal Phase III clinical study in the United States and prepares for the FDA’s Premarket Approval process. The company is also working to complete enrollment in its U.S. study and expand commercialization efforts, with a focus on developing cartilage repair solutions intended to deliver lasting improvements in pain and mobility.

Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article that discussed the company’s efforts to advance its regenerative cartilage repair technology, GelrinC, as orthopedic medicine increasingly emphasizes durable, long-term treatment outcomes. The company’s lead product is a cell-free, off-the-shelf degradable hydrogel implant designed to support the regeneration of knee cartilage, gradually resorbing over approximately six to nine months as new tissue fills the treated area. Regentis reports that its Pilot/Phase II study showed 100% greater pain improvement compared with traditional microfracture treatment, while 24-month follow-up results showed a mean MOCART score of 88.8 out of 100, an MRI-based measure of cartilage repair quality. GelrinC has received a CE mark in Europe, providing a pathway for commercialization in that market, while Regentis advances its pivotal Phase III clinical study in the United States and prepares for the FDA’s Premarket Approval process. The company is also working to complete enrollment in its U.S. study and expand commercialization efforts, with a focus on developing cartilage repair solutions intended to deliver lasting improvements in pain and mobility.

Annovis Bio (NYSE: ANVS), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy buntanetap for Alzheimer’s and Parkinson’s diseases, announced that Founder, President and CEO Maria Maccecchini, Ph.D., will participate in two industry conferences in November. At U.S. Biotech Day 2026, scheduled for Nov. 16-17 in Philadelphia, Maccecchini will join a panel discussion titled “Bridging the Translational Gap: From Discovery Insights to Clinical Proof” on Nov. 16 from 9:15-9:45 a.m. ET, followed by a company presentation from 10:15-10:30 a.m. ET highlighting Annovis’ clinical programs and upcoming milestones.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) is building its PDAOAI drug discovery engine around a compelling premise: a clue buried in a small corner of the literature can redirect an entire research program. Its Partitioned Literature Aggregation (“PLA”) algorithm is designed to uncover those clues. A liver-cancer study published in Biomedicines on October 23, 2026, now provides a concrete example of that approach reaching patient-data validation.

Canada is phasing out coal-fired electricity, but metallurgical coal presents a different economic and industrial challenge. Thermal coal is burned to generate power while metallurgical coal is used to produce coke, a key ingredient in the manufacture of steel. This distinction is central to the Canadian coal industry’s argument that the government should include coking coal on the list of critical minerals.

The race to expand AI is forcing major companies to reconsider how they spend their money, with workforce reductions emerging as one consequence. Businesses are directing more resources toward data centers, automation, and specialist talent, sometimes reducing existing positions to finance these investments. Although debate about a possible AI market bubble continues to grow, the technology’s influence on employment is becoming increasingly apparent.

Abdul El-Sayed, a Democrat vying to win a U.S. Senate seat in Michigan, has become a nationally renowned figure after he built his campaign around advocating for a single payer healthcare system, popularly known as Medicare for all. During a recent campaign tour, he was accompanied by Democratic firebrand Alexandria Ocasio-Cortez (AOC). The animated crowds that attended all their rallies pose the question, is universal healthcare going to be a deciding factor as to who wins different races during the midterms next week?

Several of the Magnificent Seven have released their earnings reports or are due to do so over the coming days. These reports are coming under stringent investor scrutiny in ways that haven’t been seen in recent times. Several factors explain why investors aren’t giving Big Tech a pass as easily as they once did.

Fatih Birol, executive director of the International Energy Agency, has credited China with driving meaningful progress in the global energy transition, saying the country’s clean energy achievements have set a pace that other economies have struggled to match. Birol made the remarks at the Berlin Global Dialogue, where the energy market upheaval following the outbreak of Middle East hostilities dominated the agenda.

Bitcoin faced renewed selling pressure late last week as spot exchange-traded funds recorded heavy withdrawals. Data showed that Bitcoin spot ETFs registered combined outflows of about $773 million between October 22 and 23. Over the same two-day period, Bitcoin fell 3.45%, extending its decline as the market moved toward the weekend.

A shareholder in a cryptocurrency company has filed a lawsuit involving Donald Trump and WLF (World Liberty Financial), bringing fresh attention to the legal risks surrounding businesses connected to digital assets and political figures. The case raises questions about corporate decisions, shareholder rights, and the responsibilities of people linked to companies operating in the fast-changing crypto industry.

Nightfood Holdings (OTCQB: NGTFD), operating as TechForce Robotics, announced its placement in an AINewsWire editorial titled “Semiconductor Equipment Market Outlook: How AI Demand Is Driving Test, Packaging and Inspection Growth.” The editorial examines how growing demand for artificial intelligence (“AI”) infrastructure is driving investment in semiconductor manufacturing, testing, packaging and inspection equipment. Citing TrendForce estimates, the article notes that capital spending by the nine largest cloud companies is projected to reach approximately $830 billion in 2026, highlighting the importance of automated production and inspection technologies in supporting semiconductor manufacturing.

Autonomous drones and other unmanned systems are designed to carry out missions with varying degrees of human oversight. But their capabilities depend on more than their ability to fly or navigate. They also depend on communications links connecting platforms with operators, onboard control systems that execute mission instructions, and reliable data that supports decision-making.

TransCode Therapeutics (NASDAQ: RNAZ), a clinical-stage biopharmaceutical company developing RNA-based therapeutics and immuno-oncology treatments for high-risk and advanced cancers, announced that its board of directors has initiated a formal strategic process to evaluate opportunities to maximize the value of the company and its oncology portfolio, including lead product candidate TTX-MC138. The review will consider potential licensing or sales of individual assets, development and commercialization partnerships, portfolio transactions, business combinations and other strategic alternatives. TransCode has engaged Tungsten Advisors as its exclusive strategic financial adviser for the process.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a global provider of smart retail technology, announced that it will release its financial results for the third quarter ended Sept. 30, 2026, after market close on Wednesday, Nov. 11, 2026. The company will host a conference call to discuss the results at 5 p.m. ET the same day. Investors can access the call by dialing 1-877-317-6789 (U.S. toll-free), 972 3-374-1008 (Israel) or 1-412-317-6789 (international). A live webcast will also be available.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

Safe Pro Group (NASDAQ: SPAI), a developer of artificial intelligence (“AI”)-enabled defense, security and situational awareness solutions, announced that it has completed all research milestones under its Phase I Small Business Innovation Research (“SBIR”) contract awarded by AFWERX, the innovation arm of the Department of the Air Force. Awarded in July, the contract focused on developing an AI dataset using images of foreign object debris and damage (“FOD”) commonly encountered at U.S. Air Force and civilian airfields. Under the program, Safe Pro demonstrated its SpotlightAI(TM) computer vision technology for detecting small objects, collected and analyzed high-resolution imagery and prepared technical project reports. Subject to AFWERX review and determination, the company intends to pursue additional SBIR-funded development contracts.

Knightscope (NASDAQ: KSCP), a security technology company developing the nation’s first Autonomous Security Force, announced that it will release financial results for the third quarter ended Sept. 30, 2026, after market close on Thursday, Nov. 12, 2026. The company will host a conference call featuring members of its executive management team to discuss the results and provide additional commentary. The call is scheduled to begin at 4:30 p.m. ET (1:30 p.m. PT) the same day.

Stocktoberfest presented by Tradr ETFs, Stocktwits’ flagship annual event held in New York City from October 5 to 7, was designed around a simple idea: put the right people in the same room and let the conversations happen. More than 350 ticketed guests attended, including 40 financial creators with a combined audience of more than 11 million followers.

This article has been disseminated on behalf of BTQ Technologies Corp. and may include paid advertising.

BOXABL (NASDAQ: BXBL) is exploring opportunities to apply its factory-built construction model to the growing data center market through a conceptual Server Pod design intended to house artificial intelligence and cloud-computing infrastructure. The company has outlined potential configurations ranging from compact 10-foot and 20-foot units to 40-foot enclosures and a proposed 2,500-square-foot “Server Tron.” The initiative comes as JLL projects approximately 100 gigawatts of new global data center capacity could come online between 2026 and 2030, potentially requiring $3 trillion in investment. BOXABL believes factory-based manufacturing could help address construction costs and deployment timelines by preparing structures in controlled production environments before transporting them to customer sites.

Sentinel AI and Webull (NASDAQ: BULL) announced a joint pilot program designed to help publicly traded companies engage retail investors through real-time sentiment analysis and targeted investor communications. The initiative combines Sentinel AI’s technology for monitoring bullish and bearish narratives across social media and online news with Webull’s Corporate Connect Service, which provides verified company pages within its trading platform. The program enables companies to identify emerging investor sentiment and work with their investor relations (“IR”) teams to develop approved responses delivered directly through Webull, which has more than 29 million registered users worldwide. According to JPMorgan data cited in the announcement, retail investors accounted for as much as 36% of U.S. stock market trading in 2025, compared with a 10-year average of approximately 12%.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Earth Science Tech (OTCQB: ETST) is leveraging artificial intelligence (“AI”), proprietary software and its in-house IT expertise to improve operational efficiency, reduce costs and support sustainable growth across its pharmacy and telemedicine businesses. Led by Chief Technology Officer Chris Rose, the company has developed an integrated software and data platform connecting its pharmacies, curative telehealth business and My Online Consultation physician network. The platform automates administrative workflows and supports functions such as inventory, invoicing, shipping and purchasing, while creating opportunities to offer its technology to other clinics as a white-label service. ETST also uses customer relationship management systems and proprietary marketing tools to personalize patient communications, encourage retention and strengthen brand loyalty. By combining AI-assisted development with human oversight, the company aims to expand its technology capabilities, introduce new services and build long-term shareholder value.

Mobilicom (NASDAQ: MOB), a provider of cybersecure solutions for drones and robotics, announced its participation in the annual Air Reserve Component Weapons and Tactics Conference (“ARC WEPTAC”) and Domestic Capability Priorities conference, taking place Oct. 26-30, 2026, in Tucson, Arizona. The event brings together military leaders, defense decision-makers and industry representatives to assess operational capability gaps and modernization priorities. Mobilicom is demonstrating its portfolio of software and hardware solutions, with a focus on SwarmiX, its recently launched autonomous swarm management system designed to support coordinated drone fleets through scalable connectivity, high-bandwidth data transmission and resilient communications in contested electromagnetic environments.

A combination of two immunotherapy drugs has significantly extended survival in patients with one of the deadliest forms of lung cancer, with trial data showing median survival nearly doubling against the current standard of care. Results from the Phase 3 study involving 563 patients were presented during a conference of the European Society for Medical Oncology in Madrid and also published simultaneously in the New England Journal of Medicine.

Europe’s move toward electric cars is doing more than cutting tailpipe pollution. It is also helping the continent spend less on imported oil at a time when global fuel prices have become unstable. New research suggests that the European Union saved close to $3.1 billion in oil-import costs from March to August 2026 because more drivers switched from gasoline and diesel vehicles to electric ones.

You might have seen in the news that Russia sold about 6.2 tons of its gold reserves in September. This, according to credible reports, is the 10 th straight month that Moscow has sold some of its bullion reserves. As an investor, what does this tell you ?

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced that results from its ALIGN-ACS pilot study evaluating its 3D electrocardiogram (“ECG”) technology for heart attack assessment will be presented at the Transcatheter Cardiovascular Therapeutics (“TCT”) 2026 conference in San Diego. The presentation, scheduled for Nov. 1 at 1:20 p.m. Pacific time, will be delivered by Dr. Graham Nichol of the University of Washington. The study enrolled 132 emergency department patients presenting with chest pain at two clinical sites in Belgrade, Serbia, and compared the HeartBeam System, a credit card-sized, three-lead device, with a standard 12-lead ECG for detecting acute coronary syndrome.

Nightfood Holdings (OTCQB: NGTF), operating as TechForce Robotics, was featured in an AINewsWire editorial examining growing demand for semiconductor manufacturing equipment and automated inspection technologies amid expanding artificial intelligence (“AI”) infrastructure investment. The editorial highlights Nightfood’s recent acquisition of designs, technology and expertise for automated optical inspection (“AOI”) equipment used in chip-on-wafer-on-substrate (“CoWoS”) advanced semiconductor packaging. The company plans to establish a 20,000-square-foot manufacturing facility in Taiwan, targeting initial production of 10 to 15 units monthly and first sales and shipments in late November or early December 2026, subject to production readiness, customer demand and regulatory requirements. The editorial also cites industry forecasts projecting worldwide semiconductor equipment sales of $165.9 billion in 2026.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

VolitionRx Limited (NYSE American: VNRX), a multinational epigenetics company, announced that it has signed a nonbinding letter of intent (“LOI”) with Denmark-based Missionpharma A/S to explore the development and global commercialization of its prototype lateral flow technology (“LFT”) for detecting NETosis, a process associated with inflammation. The collaboration will initially focus on evaluating the finger-prick diagnostic test for neonatal sepsis, with potential applications in low- and middle-income countries and humanitarian emergency settings. Missionpharma, which supplies healthcare products to United Nations agencies, government health ministries and other institutions, could support low-cost manufacturing, clinical studies and distribution.

AINewsWire Editorial Coverage : Conversations about artificial intelligence tend to center on models, semiconductors and server farms. Before any of those processors can do useful work, though, each one has to be packaged, checked for defects and turned out at scale, and all of that takes place inside manufacturing plants. TrendForce estimates that capital spending by the nine biggest cloud companies is projected to reach roughly $830 billion in 2026. Whether those dollars become functioning hardware hinges on the automated production and inspection tools that support the buildout. Operating as TechForce Robotics, Nightfood Holdings Inc. (OTCQB: NGTFD) ( profile ) is pushing into this link of the production chain. Through a recent deal , the company took ownership of a defined set of CoWoS automated optical inspection technology, and a production site of 20,000 square feet is being planned for Taiwan. First deliveries are slated for late November or early December 2026, though timing will depend on whether production is ready and on orders coming in from customers. Nightfood is working to be recognized as a source of innovation across the wider AI and automation landscape, alongside established names such as KLA Corporation (NASDAQ: KLAC), Onto Innovation Inc. (NYSE: ONTO), Applied Optoelectronics Inc. (NASDAQ: AAOI) and…

This article has been disseminated on behalf of Purecore Metals Inc. and may include paid advertising.

This article has been disseminated on behalf of Evolve Royalties Ltd. and may include paid advertising.

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and mobility solutions, announced strong dealer interest following the soft launch of its 2027 Warrior 1500XD and Sentinel 1500 HVAC Crew utility terrain vehicles (“UTVs”) at Equip Exposition, held Oct. 20-23 in Louisville, Kentucky. The company generated more than 100 prospective dealer leads and estimates initial preorder demand exceeding 100 units across the two models ahead of their official launch at the Specialty Equipment Market Association (“SEMA”) Show in November. Both vehicles feature a new 1,499cc inline four-cylinder engine platform, with the Warrior 1500XD emphasizing rugged utility and off-road capability and the Sentinel 1500 HVAC Crew offering an enclosed cab with heating, air conditioning and premium comfort features.

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage antiviral drug developer, announced that its Phase IIA clinical trial evaluating NV-387 Oral Gummies for the treatment of Ebola Bundibugyo virus disease in the Democratic Republic of Congo (“DRC”) is progressing, with advancement to Phase IIB anticipated following completion of the initial study phase. Enrollment began Sept. 23, 2026, with approximately 20 patients expected to participate in Phase IIA, which is designed to evaluate dosing regimens based on disease severity. The trial’s primary endpoint is 28-day survival, and the initial phase will conclude once the final enrolled patient completes the observation period.

A trends report published by DHL reveals key trends that are likely to determine how Black Friday pans out for retailers who are looking to capitalize on this major shopping day in 2026. The report points out key insights that could determine which businesses will benefit, or lose out, during Black Friday.

Bitcoin traded with little overall change as the Asian trading session drew to a close last week, hovering below $82,800 after surrendering gains from a rally that briefly pushed the cryptocurrency close to $85,000 late Wednesday. Weakness in technology stocks following mixed corporate earnings added pressure to market sentiment, while concerns surrounding AI investments resurfaced.

Several workers at Google’s artificial intelligence division, DeepMind, have decided to leave the company because they are unhappy with its growing role in United States military projects. Their resignations show a deep divide between employees who believe AI should be developed for peaceful and helpful purposes, and a company that is increasingly working with defense institutions.

Russia’s central bank is selling gold at its fastest pace in more than two decades as the country faces mounting financial pressure from its ongoing war in Ukraine. According to the World Gold Council, the central bank sold another six tons of gold last month, bringing its total sales thus far to 62 tons.

OpenAI has disclosed two cases where AI agents using its models interfered with in-house monitoring protections while undertaking assigned programming roles. In one incident, an AI agent disabled security alerts, while another disabled a monitoring component and later gave an inaccurate account of what it had done.

Toyota set a nine-month European sales record in 2026 on the strength of an internal product shift rather than market conquest, with electrified vehicles now making up 87% of what the company sells across the region. Combined volume across both brands edged up 0.6% to 936,042 units, but that number masks a dramatic reshaping of the lineup.

Many people have been taken by surprise as the flu season gets underway a lot earlier than had been expected in the U.S. The driver of this outbreak, especially on the West Coast, is a mutated flu version. Experts are calling for urgent vaccination drives to safeguard more people against this new threat.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

TruGolf Holdings (NASDAQ: TRUG), a producer of advanced golf simulation systems for home or entertainment venues, has engaged its newly acquired subsidiary Polymath to put the ownership records of its indoor golf franchise business onto a blockchain-based securities platform, marking the first technology deployment announced since TruGolf and Polymath officially combined October 8, 2026.